Bacterium, Genetics and Immune Response - Clinical Research Informer

Symvivo’s Oral COVID-19 Vaccine Enters Clinical Trials

XTalks

NOVEMBER 6, 2020

The Burnaby, BC-based company developed the oral DNA-based vaccine using its proprietary bacTRL Gene Therapy Platform, which uses genetically modified bifidobacteria as carriers of genetic vaccine elements on a DNA plasmid. Related: Red Meat Allergy Test Gets FDA Clearance. “We

Clinical Trials

Clinical Trials Clinical Trials Vaccination Vaccine

Medicago’s Plant-Based COVID-19 Vaccine Enters Human Trials

XTalks

NOVEMBER 10, 2020

Interim results of the trial show that all participants developed an antibody response after two doses of the COVID-19 adjuvanted vaccine candidate. Adjuvants are used to help stimulate stronger vaccine immune responses. These are very promising results. Plant-Based Vaccine Technology.

Vaccination

Vaccination Vaccine Trials Immune Response

Clinical Research Informer

Symvivo’s Oral COVID-19 Vaccine Enters Clinical Trials

Medicago’s Plant-Based COVID-19 Vaccine Enters Human Trials

Webinars

Stay Connected